The Widex Allure RIC 440 is a premium prescription hearing aid released in 2025, priced at $4,398. In HearAdvisor's lab testing, it earns an A grade with a SoundScore of 4.52/5, ranking #7 among 35 prescription hearing aids tested—placing it in the top 17% of its category.
Speech performance is a clear strength. Speech in quiet scores a strong 4.3/5, sitting 0.87 points above the category average. Speech in noise reaches 2.5/5, which is 0.97 points above average for prescription aids—though still only mixed in absolute terms, reflecting the inherent difficulty of noisy environments for all hearing aids.
The most notable weakness is feedback handling, which scores just 1.7/5—a full 3.04 points below the category average of 4.74. This low score indicates the device struggled under our standardized feedback challenge conditions. Own voice scores a solid 3.0/5, and music streaming lands at 2.7/5, both slightly above their respective category averages.
At this price point, the Allure RIC 440 competes with devices like the Oticon Intent (4.70/5) and Phonak Sphere Infinio (4.64/5). It's best suited for users who prioritize speech clarity in everyday listening situations and can work with their hearing care professional to manage potential feedback concerns. The rechargeable battery and streaming compatibility with both iPhone and Android add practical convenience.
